This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medical Marijuana Inc., Corporate Update- Significant Revenue And Net Income Growth 1st Quarter- Division And Corporate Holdings Update













SAN DIEGO, April 4, 2013 /PRNewswire/ -- Medical Marijuana Inc (OTC Pink: MJNA) is pleased to inform shareholders that all Company divisions are healthy and foresee increasing revenues from overall operations. With the close of the first quarter of 2013, the Company has seen its revenue and net income increase significantly over the prior quarter. Updates are provided for each of our portfolio companies and investments as we enter into the second quarter – where we expect explosive growth, fueled by new products coming onto the market, further market penetration, product awareness through extensive advertising with the companies first ever significant print-television and internet campaigns, as well as with key marketing and distribution agreements with non-industry related distribution companies.   

Medical Marijuana Inc. has spent years developing its portfolio of products and services. This April, the company launches more innovative products and services than it has combined since its inception over four years ago. This month sets the stage and tone for it's over the counter products.

Update on current events-

CanChew Biotechnologies – has two developmental product arms to bring the cannabinoid based chewing gum to market.  In the United States the CanChew Advantage Chewing gum will be available on an over the counter basis and online and without prescription or the need for a medical marijuana recommendation\card.  Each piece will contain approximately 7 mg of naturally-derived CBD to provide health and wellness benefits to consumers.  The company has spent considerable amounts of resources to develop this product and will be launching sales later this month.    

Canchew successfully carried out its soft launch, as well as its free product trial and market survey in December of last year. The free product trial and market survey proved invaluable with its anecdotal feedback and survey information. The company had over 1500 applicants for the free product trial and for those who participated in the free product trial we will have a "thank you" in the form of a special twelve month subscription discount.  

1 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs